As of 2025-05-08, the Fair Value of Virpax Pharmaceuticals Inc (VRPX) is -118.22 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.67 USD, the upside of Virpax Pharmaceuticals Inc is -17,758.18%.
With the market price of 0.67 USD and our fair value calculation, Virpax Pharmaceuticals Inc (VRPX) is not a good investment. Investing in VRPX stocks now will result in a potential loss of 17,758.18%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -4.34 | -12.06 | -21.65 | -15.19 | -12.07 | -13.06 |
| YoY growth | -31.24% | -177.82% | -79.58% | 29.84% | 20.56% | -47.65% |
| Market Cap (mil) | 0.34 |
| P/E | |
| Forward P/E |
| EPS | -23.64 |
| Avg earnings growth rate | -47.65% |
| TTM earnings | -12.07 |